National and Kapodistrian University of Athens
Μελέτη της αποτελεσματικότητας και της ασφάλειας χορήγησης εκλεκτικού αναστολέα της κυκλοοξυγενάσης-2 για την αντιμετώπιση του μετεγχειρητικού πόνου σε ασθενείς που υποβάλλονται σε ολική αρθροπλαστική ισχίου και γόνατος
Abstract
dc:descriptionBackground and objective: The postoperative pain management in total hip and knee arthroplasty patients, the majority of whom are elderly people with concurrent diseases, aims at the prevention of the changes that the pain will cause to the cardiovascular system, the coagulation, the gastrointestinal system and the patients' functional recovery. The effect of the preoperative and postoperative administration of parecoxibin the postoperative pain and the need for analgetic drugs along with their possible side effectes were investigated in this study. Method: 31 ASA status I‐III patients scheduled for total hip or knee arthroplasty were randomized into 2 groups: GROUP 1: Administration of 40 mg of parecoxib (iv) in 100ml N/S 0.9%before the operation and at 12 hour intervals within a three‐day period. GROUP 2: Administration of the placebo (iv) 100ml N/S 0.9% and at 12hour intervals within a three‐day period. Postoperative analgesia was administered with the use of an electronic epidural pump with continuous infusion and patient control delivery of a combination of ropivacaine/morfine solution. The following were estimated: the intensity of the pain using the verbal numerical scale(NRS), the consumption of the analgetic solution 1, 2, 12 and 24 hours postoperative, the possible side effects per systems, the patients satisfaction of analgesia, the need for further medical treatment and the blood loss. Results: The placebo group presented substantially increased needs for analgesia in comparison to the patients to whom parecoxib was adminestered and the satisfaction of analgesia was lower. Furthermore, the side effects and the need for further medical treatment were higher in the placebo group. There was not documented any statistically important difference in the blood loss. Conclusions: The perioperative administration of parecoxib as an analgesic factor to patients submitted to total hip and knee arthroplasty in conjuction with epidural analgesia reduces the postoperative pain and does not increase the frequency of the occurrence of side effects and the perioperative blood loss.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dimitriou, Eftychia
- Δημητρίου, Ευτυχία
Subjects
dc:subject × 16- Παρεξοκίμπη
- Μετεγχειρητικός πόνος
- Ασφάλεια
- Αποτελεσματικότητα
- Ολική αρθροπλαστική γόνατος - ισχύου
- Parecoxib
- Postoperative pain
- Safety
- Effectiveness
- Total hip and knee arthroplasty
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Επιστήμες Υγείας
- Medical and Health Sciences
- Clinical Medicine
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40690